Post by
SPCEO1 on May 11, 2022 11:47am
Canaccord Warming Back Up to THTX?
As we are painfully aware, the Canaccord analyst has had THTX in his penalty box for a long time. But he put out a prompt report this morning (recall it took him almost two weeks, which is incredible, to put out a report on THTX's last quarterly earnigns call) noting the start of the phase 1b which included a commitment to factor cancer into his model once proof of concept is seen.
When might that be seen? It could actually be earlier than we have been thinking in the phase 1b. If everything went perfectly optimally (which basically never happens) it would be possible we saw results from the second scans confirming preliminary efficacy by the end of June. How, you ask? Well, the pahse 1b got started earlier than we expected and some/all of the first three 300 mg dose patients may have rolled right into the phase 1b. If so, the phase 1b effectively started when those first three patients got their first dose, which I am guessing occurred in late March since in mid April they had complete their first cycle of treatment (based on what was said on t he mid-April conference call).
Now, I don't know the specific rules areound declaring preliminary signs of efficacy. First I have to assume you need at least two instances of tumor regression afer twelve weeks and two scans. This must have to be in the same cancer type as well. So, if two of those first three patients has the same cancer type and both showed tumor regression, then THTX can declare preliminary signs of efficacy, I think (any help with the rules around declaring preliminary signs of effcicacy from those in the know would be appreciated). The chances of all the conditions being met are tiny but it is fun to think about.
My contact who mingled with the THTX honchos before the annual meeting yesterday heard there was to be a discussion at the board meeting following the AGM yesterday discussing some recent input from the investigators on the trial. Could that have been the results of the first scan? Were those reults positive or negative? We can only speculate but thereis a very small chance THTX is already half way there to declaring preliminary efficacy.
Then we can see how much credit Canaccord and the other analysts will give THTX for their cancer program. Whatever they give will be heavily discounted due to how early we are still in the testing program for TH-1902. But at least it will be something!
If you really want to keep dreaming, then hope that two of those first three 300mg patients had ovarian cancer and both show tumor regression. If that tumor regression is as good as seen with normal docetaxel patients where docetaxel is the first line of therapy for ovarian cancer, then things could speed up very quickly for TH-1902. A phase 2 study would be started pronto and, if TH-1902 was to reveal that it is better and safer than normal docetaxel treatments, it might get anaccelerated approval sometime in 2023 and it should then quickly become the first line treatment for ovarian cancer.
OK, now it is time to come backdown to earth as the chances of any of that happening have to be 1 in 1000 or less. Everything would have to go right and that never happens, especially when you are dealing with very, very ill patients who have been through all sorts of cancer therapy already.
Even so, we may get a preliminary efficacy signal sooner than we thought. but it likely will not be on the optimal type of cancer from our prespective, which I believe would be ovarian.
Comment by
scarlet1967 on May 11, 2022 3:36pm
I dont think we ever agree on this subject as I said before scientists understand science salesman understand selling scientists/salesman sell the science.
Comment by
qwerty22 on May 11, 2022 4:01pm
We both agree on your statement. What we disagree on is whether the "10 cycle" thing is a scientific fact or just a rumour flying around this board. If it's a hypothetical turned into a scientific fact by this board then it has no place in a THTX PR. You want it in a PR and I'm suggesting it might be little more than gossip, consider that as a possibility.
Comment by
stockman75 on May 12, 2022 8:57am
Wonder if they are proud of the stock price and lack of confidence the market has in their company?
Comment by
Biobob on May 12, 2022 10:00am
Maybe Th will be the only ten bagger this year... it was TSX60 top gainer back in 2018.. listen if oil went to zero and interest rates negatives and AMC and Bitcoin to the sky.. nothing, nothing is impossible.
Comment by
realitycheck4u on May 11, 2022 3:34pm
This post has been removed in accordance with Community Policy
Comment by
realitycheck4u on May 11, 2022 3:25pm
This post has been removed in accordance with Community Policy